Forever young: the business of longevity drugs
The success of GLP-1s has prompted biotechs to approach the challenge differently. After years of false starts and disappointing results, longevity drugs could be on the horizon. Do immigrants from some countries commit more sex crimes? And the big business of miniatures. Guests and host: Shailesh Chitnis, global…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Economist Podcasts
See all episodes →
Similar episodes from other shows
More like Economist Podcasts →
AI and health part one: DrGPT will see you now
Tech Tonic: Defying death
Age1’s Alex Colville: “Inventing the anti-ageing pill”
The new science of ageing and the quest to live forever
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.